Ducommun (DCO) Financials

$144.07 -7.52 (-4.96%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$143.72 -0.35 (-0.25%)

As of 05/15/2026 05:46 PM Eastern

Annual Income Statements for Ducommun

This table shows Ducommun's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-75	25	20	9.04	32	29	136	29	16	22	-37
Consolidated Net Income / (Loss)	-75	25	20	9.04	32	29	136	29	16	22	-37
Net Income / (Loss) Continuing Operations	-75	25	20	9.04	32	29	136	29	16	22	-37
Total Pre-Tax Income	-107	38	7.61	10	38	32	170	33	16	27	-47
Total Operating Income	-75	29	16	24	56	46	49	40	29	42	-36
Total Gross Profit	101	107	103	123	152	138	142	144	163	197	222
Total Revenue	666	551	558	629	721	629	645	713	757	786	825
Operating Revenue	666	551	558	629	721	629	645	713	757	786	825
Total Cost of Revenue	565	444	455	507	569	491	503	568	594	589	603
Operating Cost of Revenue	565	444	455	507	569	491	503	568	594	589	603
Total Operating Expenses	176	77	87	99	96	92	94	105	134	155	257
Selling, General & Admin Expense	84	77	79	84	96	90	94	98	120	149	148
Restructuring Charge	2.13	0.18	8.36	15	0.00	2.42	0.00	6.16	15	6.44	2.24
Other Special Charges / (Income)	-	-	-	-	-	-	-	-	0.00	0.00	107
Total Other Income / (Expense), net	-31	8.90	-8.03	-14	-18	-14	122	-6.47	-13	-15	-12
Interest Expense	33	8.92	8.87	14	18	14	11	0.30	0.00	0.00	0.58
Interest & Investment Income	-	-	-	-	-	0.00	133	-12	-21	-15	-13
Other Income / (Expense), net	2.15	18	0.85	0.30	0.00	0.13	0.27	5.40	8.24	0.00	1.75
Income Tax Expense	-32	13	-12	1.24	5.30	2.81	35	4.53	0.45	5.24	-9.89
Basic Earnings per Share	($6.78)	$2.27	$1.78	$0.79	$2.82	$2.50	$11.41	$2.38	$1.16	$1.47	($2.50)
Weighted Average Basic Shares Outstanding	11.05M	11.15M	11.29M	11.39M	11.52M	11.68M	11.88M	12.07M	13.72M	14.77M	14.94M
Diluted Earnings per Share	($6.78)	$2.24	$1.74	$0.77	$2.75	$2.45	$11.06	$2.33	$1.14	$1.44	($2.50)
Weighted Average Diluted Shares Outstanding	11.05M	11.30M	11.56M	11.66M	11.79M	11.93M	12.25M	12.37M	13.97M	15.01M	14.94M
Weighted Average Basic & Diluted Shares Outstanding	11M	11.10M	11.30M	11.43M	11.61M	11.76M	11.97M	12.15M	14.64M	14.81M	14.99M

This table shows Ducommun's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	4/4/2026
Net Income / (Loss) Attributable to Common Shareholders	3.21	5.11	6.85	7.72	10	6.77	1.40	13	-64	7.44	9.92
Consolidated Net Income / (Loss)	3.21	5.11	6.85	7.72	10	6.77	1.40	13	-64	7.44	9.92
Net Income / (Loss) Continuing Operations	3.21	5.11	6.85	7.72	10	6.77	1.40	13	-64	7.44	9.92
Total Pre-Tax Income	3.24	3.77	8.74	9.95	11	6.78	1.71	16	-83	9.94	12
Total Operating Income	8.61	8.93	13	14	15	10	4.98	17	-80	14	16
Total Gross Profit	45	42	47	51	53	46	50	54	56	60	56
Total Revenue	196	192	191	197	201	197	192	202	213	216	209
Operating Revenue	196	192	191	197	201	197	192	202	213	216	209
Total Cost of Revenue	152	151	144	146	149	151	142	149	156	156	153
Operating Cost of Revenue	152	151	144	146	149	151	142	149	156	156	153
Total Operating Expenses	36	33	34	37	37	36	45	37	137	46	41
Selling, General & Admin Expense	32	31	33	36	35	34	45	36	36	38	41
Restructuring Charge	3.81	1.79	1.37	1.25	1.92	1.90	0.43	0.61	0.58	0.62	0.00
Total Other Income / (Expense), net	-5.37	-5.16	-3.88	-3.98	-3.83	-3.62	-3.26	-1.26	-2.93	-4.06	-4.01
Interest & Investment Income	-5.37	-	-3.88	-3.98	-3.83	-	-3.26	-3.01	-2.93	-3.48	-4.01
Income Tax Expense	0.03	-1.34	1.89	2.23	1.29	0.01	0.31	3.36	-19	2.50	1.79
Basic Earnings per Share	$0.22	$0.33	$0.47	$0.52	$0.69	$0.45	$0.09	$0.84	($4.30)	$0.48	$0.66
Weighted Average Basic Shares Outstanding	14.63M	13.72M	14.69M	14.78M	14.81M	14.77M	14.86M	14.94M	14.98M	14.94M	15.04M
Diluted Earnings per Share	$0.22	$0.33	$0.46	$0.52	$0.67	$0.45	$0.09	$0.82	($4.30)	$0.52	$0.64
Weighted Average Diluted Shares Outstanding	14.81M	13.97M	14.94M	14.96M	15.04M	15.01M	15.18M	15.22M	14.98M	14.94M	15.60M
Weighted Average Basic & Diluted Shares Outstanding	14.60M	14.64M	14.72M	14.75M	14.78M	14.81M	14.88M	14.92M	14.95M	14.99M	15.09M

This table details how cash moves in and out of Ducommun's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-40	1.98	-5.28	8.11	29	17	20	-30	-3.38	-5.72	8.15
Net Cash From Operating Activities	24	43	35	46	51	13	-0.57	33	31	34	-33
Net Cash From Continuing Operating Activities	24	43	35	46	51	13	-0.57	33	31	34	-33
Net Income / (Loss) Continuing Operations	-75	25	20	9.04	32	29	136	29	16	22	-37
Consolidated Net Income / (Loss)	-75	25	20	9.04	32	29	136	29	16	22	-37
Depreciation Expense	27	23	23	25	28	29	28	31	33	33	34
Amortization Expense	-	-	0.00	0.00	2.67	3.16	3.35	7.27	8.22	8.51	8.33
Non-Cash Adjustments To Reconcile Net Income	104	-23	7.21	-64	-18	-19	-137	-3.16	23	-22	-19
Changes in Operating Assets and Liabilities, net	-32	19	-15	76	5.55	-29	-31	-32	-49	-7.83	-19
Net Cash From Investing Activities	-13	35	-86	-48	-95	-5.47	58	-19	-133	-14	-13
Net Cash From Continuing Investing Activities	-13	35	-86	-48	-95	-5.47	58	-19	-133	-14	-13
Purchase of Property, Plant & Equipment	-16	-17	-28	-18	-18	-13	-17	-20	-20	-14	-15
Acquisitions	0.00	0.00	-60	-31	-77	0.00	-69	0.37	-114	0.00	0.00
Sale of Property, Plant & Equipment	0.90	0.02	0.91	0.40	0.00	0.01	0.55	0.08	0.40	0.22	0.13
Other Investing Activities, net	1.51	0.00	0.29	0.00	0.00	4.95	144	-	0.00	0.00	1.98
Net Cash From Financing Activities	-50	-76	45	9.81	73	9.74	-37	-44	99	-26	55
Net Cash From Continuing Financing Activities	-50	-76	45	9.81	73	9.74	-37	-44	99	-26	55
Repayment of Debt	-390	-147	-348	-525	-363	-56	-129	-296	-159	-43	-287
Issuance of Debt	340	72	396	536	438	66	96	254	177	20	345
Issuance of Common Equity	-	-	-	-	-	-	0.00	0.00	85	0.00	0.00
Other Financing Activities, net	-0.50	-1.18	-2.61	-1.55	-2.47	-0.61	-4.05	-1.38	-3.28	-2.86	-3.22

This table details how cash moves in and out of Ducommun's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	4/4/2026
Net Change in Cash & Equivalents	4.39	16	-11	-2.66	7.86	-0.13	-6.41	6.39	14	-5.63	-6.19
Net Cash From Operating Activities	14	26	-1.65	3.46	14	18	0.77	22	18	-75	11
Net Cash From Continuing Operating Activities	14	26	-1.65	3.46	14	18	0.77	22	18	-75	11
Net Income / (Loss) Continuing Operations	3.21	5.11	6.85	7.72	10	6.77	1.40	13	-64	7.44	9.92
Consolidated Net Income / (Loss)	3.21	5.11	6.85	7.72	10	6.77	1.40	13	-64	7.44	9.92
Depreciation Expense	8.48	8.15	8.35	8.25	8.53	8.31	8.58	8.27	8.34	8.46	8.24
Amortization Expense	3.03	2.23	2.07	2.09	2.17	2.18	2.19	2.21	2.23	1.70	2.28
Non-Cash Adjustments To Reconcile Net Income	20	14	-17	-17	-21	20	7.12	-7.23	72	-85	23
Changes in Operating Assets and Liabilities, net	-21	-2.90	-1.76	2.18	15	-19	-19	6.61	-0.29	-7.67	-32
Net Cash From Investing Activities	-4.73	-3.49	-4.97	-3.32	-1.99	-3.63	-4.82	-2.19	-2.05	-4.07	-2.89
Net Cash From Continuing Investing Activities	-4.73	-3.49	-4.97	-3.32	-1.99	-3.63	-4.82	-2.19	-2.05	-4.07	-2.89
Purchase of Property, Plant & Equipment	-5.11	-3.49	-4.97	-3.32	-1.99	-3.85	-4.82	-4.27	-2.09	-4.07	-2.94
Sale of Property, Plant & Equipment	-	-	-	-	-	0.22	0.00	-	0.04	-1.99	0.05
Net Cash From Financing Activities	-5.20	-7.34	-4.18	-2.81	-4.09	-15	-2.36	-14	-2.25	73	-15
Net Cash From Continuing Financing Activities	-5.20	-7.34	-4.18	-2.81	-4.09	-15	-2.36	-14	-2.25	73	-15
Repayment of Debt	-26	-31	-12	-12	-5.07	-15	-15	-22	-3.21	-247	-1.34
Issuance of Debt	19	24	10	10	-	-	15	10	-	320	0.00
Other Financing Activities, net	1.45	-0.69	-2.53	-1.16	0.98	-0.15	-2.27	-1.82	0.96	-0.11	-13

This table presents Ducommun's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	557	515	567	31	790	837	979	1,022	1,121	1,126	1,186
Total Current Assets	263	226	221	6.32	341	410	493	527	550	568	626
Cash & Equivalents	5.45	7.43	2.15	-	40	56	76	46	43	37	45
Accounts Receivable	77	76	74	-	67	58	72	104	105	110	124
Inventories, net	115	120	122	-	112	129	151	171	199	197	183
Other Current Assets	24	22	23	6.32	122	167	193	206	203	224	273
Plant, Property, & Equipment, net	97	102	110	0.00	115	110	102	106	111	110	107
Total Noncurrent Assets	197	188	235	25	334	317	384	388	460	448	453
Goodwill	83	83	117	-	171	171	204	203	245	245	245
Intangible Assets	111	102	115	-	138	125	142	127	166	150	133
Noncurrent Deferred & Refundable Income Taxes	0.32	0.29	0.26	0.31	0.06	0.03	-	0.00	0.64	2.41	16
Other Noncurrent Operating Assets	3.77	3.49	3.10	24	25	21	38	57	48	52	60
Total Liabilities & Shareholders' Equity	557	515	567	270	790	837	979	1,022	1,121	1,126	1,186
Total Liabilities	371	303	331	90	498	508	504	496	485	446	525
Total Current Liabilities	84	86	80	40	145	143	163	199	184	176	179
Short-Term Debt	0.03	0.00	0.00	-	7.00	7.00	7.00	6.25	7.81	13	5.00
Accounts Payable	40	57	52	-	83	64	66	90	72	76	75
Accrued Expenses	36	29	28	37	38	41	41	49	42	44	51
Current Deferred Revenue	-	-	-	-	-	-	-	47	53	34	41
Other Current Liabilities	-	-	0.00	2.54	17	31	48	7.16	7.87	8.53	7.82
Total Noncurrent Liabilities	288	217	251	50	353	365	342	296	301	271	346
Long-Term Debt	241	167	216	-	301	312	279	241	257	230	299
Other Noncurrent Operating Liabilities	19	19	19	32	35	36	43	42	39	41	47
Commitments & Contingencies	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	186	212	236	180	293	329	475	526	636	680	661
Total Preferred & Common Equity	186	212	236	180	293	329	475	526	636	680	661
Total Common Equity	186	212	236	180	293	329	475	526	636	680	661
Common Stock	75	77	80	-	89	97	104	112	206	225	249
Retained Earnings	116	141	161	180	213	242	377	406	422	444	406
Accumulated Other Comprehensive Income / (Loss)	-5.60	-6.08	-6.12	-	-8.27	-9.60	-7.03	7.75	7.77	11	6.55

This table presents Ducommun's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	10/1/2022	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025	6/28/2025	9/27/2025	4/4/2026
Total Assets	990	1,006	1,119	1,142	1,132	1,132	1,130	1,128	1,141	1,249	1,185
Total Current Assets	499	515	529	557	564	569	570	578	598	681	634
Cash & Equivalents	21	17	23	27	32	29	37	31	37	51	39
Accounts Receivable	94	96	95	105	104	107	108	118	120	111	137
Inventories, net	172	194	204	215	209	202	186	198	197	193	186
Other Current Assets	211	208	206	210	218	231	240	232	244	326	271
Plant, Property, & Equipment, net	106	107	111	112	112	111	110	109	109	107	106
Total Noncurrent Assets	385	384	478	474	456	451	450	441	434	460	446
Goodwill	203	203	245	245	245	245	245	245	245	245	245
Intangible Assets	131	124	175	171	162	158	154	145	141	137	129
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	0.64	0.64	5.11	4.41	5.07	18	14
Other Noncurrent Operating Assets	50	57	59	58	49	48	46	47	43	60	58
Total Liabilities & Shareholders' Equity	990	1,006	1,119	1,142	1,132	1,132	1,130	1,128	1,141	1,249	1,185
Total Liabilities	481	478	497	507	487	476	464	436	433	600	516
Total Current Liabilities	181	181	167	190	189	186	178	172	184	334	173
Short-Term Debt	6.25	6.25	6.25	6.25	9.38	11	11	13	13	13	5.00
Accounts Payable	90	99	83	78	84	77	75	80	84	85	80
Accrued Expenses	44	29	38	46	29	40	46	33	42	194	28
Current Deferred Revenue	-	-	-	51	58	50	37	37	37	34	52
Other Current Liabilities	41	47	40	8.00	7.75	7.94	8.33	8.72	8.87	7.80	7.01
Total Noncurrent Liabilities	299	296	329	317	298	290	287	265	249	265	343
Long-Term Debt	242	239	271	265	254	251	246	230	218	215	298
Other Noncurrent Operating Liabilities	43	45	46	41	40	36	40	35	30	50	45
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	509	528	622	635	646	656	666	692	708	649	670
Total Preferred & Common Equity	509	528	622	635	646	656	666	692	708	649	670
Total Common Equity	509	528	622	635	646	656	666	692	708	649	670
Common Stock	110	111	200	205	207	209	214	238	224	230	247
Retained Earnings	398	411	414	417	429	437	447	445	477	412	416
Accumulated Other Comprehensive Income / (Loss)	0.67	5.66	8.81	13	10	10	5.25	9.03	7.49	6.82	7.05

This table displays calculated financial ratios and metrics derived from Ducommun's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	14,946,052.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	14,946,052.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-2.27
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-10.25%	-17.32%	1.37%	12.74%	14.58%	-12.78%	2.62%	10.40%	6.24%	3.90%	4.85%
EBITDA Growth	-155.57%	250.91%	-43.74%	25.92%	76.12%	-10.97%	4.18%	3.70%	-7.08%	20.82%	-87.86%
EBIT Growth	-234.69%	164.29%	-64.96%	46.98%	132.17%	-18.85%	7.70%	-8.06%	-17.78%	40.53%	-158.53%
NOPAT Growth	-234.50%	136.73%	113.03%	-49.00%	129.75%	-14.12%	-6.39%	-11.54%	-18.20%	58.44%	-150.75%
Net Income Growth	-476.90%	133.74%	-20.52%	-55.00%	259.28%	-10.13%	364.58%	-78.76%	-44.67%	97.73%	-207.76%
EPS Growth	-478.77%	133.04%	-22.32%	-55.75%	257.14%	-10.91%	351.43%	-78.93%	-51.07%	84.21%	-208.10%
Operating Cash Flow Growth	-55.68%	82.74%	-18.11%	30.49%	10.37%	-75.29%	-104.48%	5,884.07%	-4.94%	10.02%	-197.73%
Free Cash Flow Firm Growth	10.31%	-45.46%	-208.14%	1,543.00%	-207.98%	101.89%	-599.03%	86.09%	-1,275.17%	114.36%	-474.04%
Invested Capital Growth	-22.93%	-3.77%	20.97%	-113.03%	1,058.05%	5.47%	15.69%	6.12%	18.09%	3.46%	3.71%
Revenue Q/Q Growth	-4.45%	-2.50%	-0.04%	3.61%	3.26%	-4.43%	1.11%	3.40%	0.53%	0.65%	2.30%
EBITDA Q/Q Growth	-191.50%	377.46%	-22.00%	25.74%	16.67%	-4.63%	0.74%	2.86%	-3.30%	1.39%	78.10%
EBIT Q/Q Growth	-413.24%	195.23%	-40.78%	60.93%	18.80%	-7.05%	1.02%	0.46%	-7.18%	2.31%	14.89%
NOPAT Q/Q Growth	-422.44%	140.10%	103.00%	-73.23%	25.34%	-2.33%	-11.98%	3.76%	6.21%	-0.23%	10.02%
Net Income Q/Q Growth	-1,545.69%	159.09%	49.50%	-49.37%	33.79%	2.75%	294.52%	-78.11%	-15.72%	5.58%	1.94%
EPS Q/Q Growth	-1,553.66%	157.29%	48.72%	-50.00%	34.15%	2.51%	290.81%	-78.29%	-21.38%	6.06%	2.99%
Operating Cash Flow Q/Q Growth	-47.07%	10.48%	-17.70%	11.47%	55.09%	-61.18%	52.16%	164.92%	-15.17%	-19.10%	-155.95%
Free Cash Flow Firm Q/Q Growth	49.68%	-52.09%	18.22%	1,204.46%	-3,268.46%	122.65%	-363.26%	86.27%	11.78%	-61.83%	-261.22%
Invested Capital Q/Q Growth	-22.35%	-1.75%	1.38%	-112.17%	11.79%	-0.07%	5.66%	-1.26%	-2.44%	0.28%	11.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	15.13%	19.35%	18.48%	19.48%	21.11%	21.90%	22.07%	20.25%	21.56%	25.08%	26.87%
EBITDA Margin	-6.95%	12.69%	7.05%	7.87%	12.09%	12.34%	12.53%	11.77%	10.30%	11.97%	1.39%
Operating Margin	-11.31%	5.31%	2.80%	3.80%	7.80%	7.24%	7.57%	5.58%	3.82%	6.64%	-3.92%
EBIT Margin	-10.99%	8.54%	2.95%	3.85%	7.80%	7.26%	7.62%	6.34%	4.91%	6.64%	-3.71%
Profit (Net Income) Margin	-11.24%	4.59%	3.60%	1.44%	4.50%	4.64%	21.00%	4.04%	2.10%	4.00%	-4.12%
Tax Burden Percent	70.25%	66.28%	263.86%	87.97%	85.96%	91.22%	79.50%	86.40%	97.25%	85.34%	77.46%
Interest Burden Percent	145.69%	81.03%	46.17%	42.41%	67.15%	70.08%	346.87%	73.74%	44.09%	70.69%	143.38%
Effective Tax Rate	0.00%	33.72%	-163.86%	12.03%	14.04%	8.78%	20.50%	13.60%	2.75%	14.66%	0.00%
Return on Invested Capital (ROIC)	-11.89%	5.11%	10.05%	10.76%	19.24%	7.20%	6.09%	4.87%	3.55%	5.10%	-2.50%
ROIC Less NNEP Spread (ROIC-NNEP)	-21.85%	8.39%	-1.29%	107.76%	-87.88%	2.55%	47.01%	2.15%	-2.22%	-1.01%	-7.39%
Return on Net Nonoperating Assets (RNNOA)	-21.97%	7.59%	-1.08%	-6.42%	-5.51%	2.18%	27.63%	0.88%	-0.81%	-0.33%	-2.55%
Return on Equity (ROE)	-33.86%	12.70%	8.97%	4.35%	13.73%	9.38%	33.72%	5.75%	2.74%	4.78%	-5.05%
Cash Return on Invested Capital (CROIC)	14.02%	8.95%	-8.93%	0.00%	-101.82%	1.88%	-8.46%	-1.06%	-13.04%	1.70%	-6.14%
Operating Return on Assets (OROA)	-11.22%	8.77%	3.05%	8.10%	13.69%	5.61%	5.41%	4.52%	3.47%	4.65%	-2.64%
Return on Assets (ROA)	-11.48%	4.71%	3.71%	3.02%	7.90%	3.58%	14.93%	2.88%	1.49%	2.80%	-2.94%
Return on Common Equity (ROCE)	-33.86%	12.70%	8.97%	4.35%	13.73%	9.38%	33.72%	5.75%	2.74%	4.78%	-5.05%
Return on Equity Simple (ROE_SIMPLE)	-40.32%	11.91%	8.52%	5.02%	11.09%	8.86%	28.56%	5.47%	2.50%	4.61%	0.00%
Net Operating Profit after Tax (NOPAT)	-53	19	41	21	48	42	39	34	28	45	-23
NOPAT Margin	-7.92%	3.52%	7.39%	3.34%	6.70%	6.60%	6.02%	4.82%	3.71%	5.66%	-2.74%
Net Nonoperating Expense Percent (NNEP)	9.97%	-3.28%	11.34%	-96.99%	107.12%	4.65%	-40.92%	2.72%	5.77%	6.12%	4.88%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	4.45%	3.12%	4.82%	-2.34%
Cost of Revenue to Revenue	84.87%	80.65%	81.52%	80.52%	78.89%	78.10%	77.93%	79.75%	78.44%	74.92%	73.13%
SG&A Expenses to Revenue	12.58%	14.01%	14.18%	13.35%	13.31%	14.28%	14.50%	13.80%	15.82%	17.62%	17.51%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.44%	14.04%	15.68%	15.68%	13.31%	14.66%	14.50%	14.67%	17.74%	18.44%	30.79%
Earnings before Interest and Taxes (EBIT)	-73	47	16	24	56	46	49	45	37	52	-31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-46	70	39	50	87	78	81	84	78	94	11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.97	1.35	1.37	2.30	2.00	1.91	1.18	1.15	1.19	1.38	2.15
Price to Tangible Book Value (P/TBV)	0.00	10.21	93.28	2.30	0.00	18.63	4.32	3.10	3.38	3.26	4.99
Price to Revenue (P/Rev)	0.27	0.52	0.58	0.66	0.81	1.00	0.86	0.85	1.00	1.20	1.72
Price to Earnings (P/E)	0.00	11.31	16.05	45.87	18.00	21.56	4.11	21.00	47.71	29.87	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	8.84%	6.23%	2.18%	5.56%	4.64%	24.31%	4.76%	2.10%	3.35%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.07	1.20	1.19	0.00	1.52	1.51	1.12	1.11	1.14	1.29	1.83
Enterprise Value to Revenue (EV/Rev)	0.62	0.81	0.96	0.66	1.18	1.42	1.19	1.13	1.30	1.46	2.04
Enterprise Value to EBITDA (EV/EBITDA)	0.00	6.37	13.64	8.37	9.78	11.48	9.49	9.60	12.60	12.17	147.05
Enterprise Value to EBIT (EV/EBIT)	0.00	9.46	32.54	17.11	15.16	19.54	15.62	17.82	26.43	21.95	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	22.98	13.00	19.70	17.64	21.48	19.76	23.42	34.91	25.72	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.53	10.29	15.13	8.96	16.71	70.69	0.00	24.64	31.60	33.53	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	6.68	13.13	0.00	0.78	0.00	82.36	0.00	0.00	0.00	77.23	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.30	0.79	0.92	0.00	1.05	0.97	0.60	0.47	0.42	0.36	0.46
Long-Term Debt to Equity	1.30	0.79	0.92	0.00	1.03	0.95	0.59	0.46	0.40	0.34	0.45
Financial Leverage	1.01	0.90	0.83	-0.06	0.06	0.85	0.59	0.41	0.36	0.32	0.34
Leverage Ratio	2.95	2.70	2.42	1.44	1.74	2.62	2.26	2.00	1.84	1.70	1.72
Compound Leverage Factor	4.30	2.18	1.12	0.61	1.17	1.83	7.84	1.47	0.81	1.20	2.47
Debt to Total Capital	56.44%	44.04%	47.84%	0.00%	51.26%	49.20%	37.63%	31.94%	29.39%	26.20%	31.45%
Short-Term Debt to Total Capital	0.01%	0.00%	0.00%	0.00%	1.17%	1.08%	0.92%	0.81%	0.87%	1.35%	0.52%
Long-Term Debt to Total Capital	56.44%	44.04%	47.84%	0.00%	50.09%	48.12%	36.71%	31.13%	28.52%	24.85%	30.93%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	43.56%	55.96%	52.16%	100.00%	48.74%	50.80%	62.37%	68.06%	70.61%	73.80%	68.55%
Debt to EBITDA	-5.20	2.39	5.49	0.00	3.53	4.11	3.54	2.94	3.40	2.57	26.59
Net Debt to EBITDA	-5.08	2.28	5.44	0.00	3.08	3.38	2.60	2.39	2.85	2.18	22.62
Long-Term Debt to EBITDA	-5.20	2.39	5.49	0.00	3.45	4.02	3.45	2.87	3.30	2.44	26.15
Debt to NOPAT	-4.57	8.62	5.24	0.00	6.37	7.68	7.37	7.18	9.42	5.44	-13.43
Net Debt to NOPAT	-4.46	8.24	5.19	0.00	5.55	6.32	5.41	5.84	7.89	4.61	-11.43
Long-Term Debt to NOPAT	-4.57	8.62	5.24	0.00	6.22	7.51	7.19	7.00	9.14	5.16	-13.21
Altman Z-Score	1.73	2.64	2.36	32.45	2.53	2.46	2.43	2.52	2.64	3.11	3.19
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.15	2.62	2.75	0.16	2.36	2.87	3.03	2.64	2.99	3.24	3.50
Quick Ratio	0.99	0.97	0.95	0.00	0.74	0.80	0.91	0.75	0.80	0.84	0.95
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	62	34	-37	529	-571	11	-54	-7.51	-103	15	-56
Operating Cash Flow to CapEx	157.99%	254.74%	132.73%	268.49%	279.06%	100.85%	-3.46%	166.68%	162.50%	245.79%	-221.11%
Free Cash Flow to Firm to Interest Expense	1.86	3.80	-4.13	37.93	-30.93	0.79	-4.83	-25.47	0.00	0.00	-95.53
Operating Cash Flow to Interest Expense	0.71	4.85	3.99	3.31	2.76	0.92	-0.05	110.78	0.00	0.00	-57.50
Operating Cash Flow Less CapEx to Interest Expense	0.26	2.95	0.99	2.08	1.77	0.01	-1.51	44.32	0.00	0.00	-83.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.02	1.03	1.03	2.11	1.76	0.77	0.71	0.71	0.71	0.70	0.71
Accounts Receivable Turnover	7.92	7.18	7.43	0.00	0.00	10.05	9.91	8.09	7.26	7.34	7.04
Inventory Turnover	4.38	3.77	3.76	0.00	0.00	4.06	3.59	3.53	3.21	2.98	3.18
Fixed Asset Turnover	6.81	5.56	5.27	0.00	0.00	5.59	6.08	6.83	6.96	7.11	7.60
Accounts Payable Turnover	11.38	9.12	8.35	0.00	0.00	6.70	7.74	7.28	7.31	7.96	8.02
Days Sales Outstanding (DSO)	46.08	50.82	49.14	0.00	0.00	36.32	36.84	45.13	50.30	49.75	51.82
Days Inventory Outstanding (DIO)	83.38	96.69	97.08	0.00	0.00	89.80	101.66	103.46	113.84	122.67	114.89
Days Payable Outstanding (DPO)	32.07	40.01	43.69	0.00	0.00	54.46	47.19	50.17	49.91	45.85	45.52
Cash Conversion Cycle (CCC)	97.39	107.50	102.53	0.00	0.00	71.66	91.31	98.43	114.23	126.56	121.18
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	386	372	449	-59	561	592	685	727	858	888	921
Invested Capital Turnover	1.50	1.45	1.36	3.22	2.87	1.09	1.01	1.01	0.96	0.90	0.91
Increase / (Decrease) in Invested Capital	-115	-15	78	-508	620	31	93	42	131	30	33
Enterprise Value (EV)	415	445	536	414	853	892	768	805	982	1,146	1,680
Market Capitalization	180	286	322	414	584	629	558	605	760	941	1,422
Book Value per Share	$16.76	$18.98	$20.80	$15.78	$25.32	$28.11	$39.81	$43.46	$43.58	$46.18	$44.30
Tangible Book Value per Share	($0.67)	$2.50	$0.31	$15.78	($1.43)	$2.88	$10.83	$16.14	$15.43	$19.51	$19.05
Total Capital	426	379	452	180	601	648	761	773	901	925	966
Total Debt	241	167	216	0.00	308	319	286	247	265	242	304
Total Long-Term Debt	241	167	216	0.00	301	312	279	241	257	230	299
Net Debt	235	159	214	0.00	268	262	210	201	222	205	259
Capital Expenditures (CapEx)	15	17	27	17	18	13	16	20	19	14	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	174	132	139	-34	163	218	261	288	331	368	407
Debt-free Net Working Capital (DFNWC)	180	140	141	-34	203	274	337	334	374	405	452
Net Working Capital (NWC)	180	140	141	-34	196	267	330	328	366	393	447
Net Nonoperating Expense (NNE)	22	-5.90	21	12	16	12	-97	5.59	12	13	11
Net Nonoperating Obligations (NNO)	200	159	214	-239	268	262	210	201	222	205	259
Total Depreciation and Amortization (D&A)	27	23	23	25	31	32	32	39	41	42	42
Debt-free, Cash-free Net Working Capital to Revenue	26.16%	24.01%	24.84%	-5.35%	22.67%	34.65%	40.39%	40.41%	43.70%	46.78%	49.30%
Debt-free Net Working Capital to Revenue	26.98%	25.36%	25.22%	-5.35%	28.16%	43.63%	52.22%	46.90%	49.36%	51.50%	54.79%
Net Working Capital to Revenue	26.97%	25.36%	25.22%	-5.35%	27.19%	42.51%	51.13%	46.02%	48.33%	49.92%	54.18%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($6.63)	$2.27	$1.78	$0.79	$2.82	$2.50	$11.41	$2.38	$1.16	$2.13	($2.27)
Adjusted Weighted Average Basic Shares Outstanding	11.05M	11.15M	11.29M	11.39M	11.52M	11.68M	11.88M	12.07M	13.72M	14.77M	14.94M
Adjusted Diluted Earnings per Share	($6.63)	$2.24	$1.74	$0.77	$2.75	$2.45	$11.06	$2.33	$1.14	$2.10	($2.27)
Adjusted Weighted Average Diluted Shares Outstanding	11.05M	11.30M	11.56M	11.66M	11.79M	11.93M	12.25M	12.37M	13.97M	15.01M	14.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	11.10M	11.20M	11.34M	11.43M	11.61M	11.76M	11.97M	12.15M	14.64M	14.81M	14.99M
Normalized Net Operating Profit after Tax (NOPAT)	12	19	17	34	48	44	39	40	42	50	54
Normalized NOPAT Margin	1.79%	3.54%	3.01%	5.39%	6.70%	6.95%	6.02%	5.57%	5.58%	6.36%	6.56%
Pre Tax Income Margin	-16.00%	6.92%	1.36%	1.63%	5.24%	5.08%	26.41%	4.68%	2.16%	4.69%	-5.31%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.19	5.27	1.86	1.74	3.04	3.34	4.39	153.18	0.00	0.00	-52.60
NOPAT to Interest Expense	-1.58	2.17	4.65	1.51	2.62	3.04	3.47	116.53	0.00	0.00	-38.92
EBIT Less CapEx to Interest Expense	-2.64	3.37	-1.15	0.50	2.05	2.43	2.94	86.72	0.00	0.00	-78.60
NOPAT Less CapEx to Interest Expense	-2.03	0.27	1.64	0.27	1.63	2.12	2.02	50.06	0.00	0.00	-64.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Ducommun's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025	4/4/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	14,946,052.00	14,986,947.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	14,946,052.00	14,986,947.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.50	0.66
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.18%	2.11%	5.33%	5.17%	2.63%	2.63%	1.71%	2.67%	5.53%	9.38%	8.59%
EBITDA Growth	-10.55%	-11.94%	14.01%	34.76%	29.06%	6.57%	18.70%	21.17%	-367.63%	15.63%	66.53%
EBIT Growth	-34.86%	-23.76%	23.05%	53.62%	77.33%	12.78%	31.33%	35.86%	-624.37%	34.61%	215.98%
NOPAT Growth	-24.22%	32.50%	79.22%	202.87%	58.61%	-14.15%	32.30%	25.34%	-513.68%	0.94%	226.73%
Net Income Growth	-62.03%	-36.77%	30.93%	225.36%	215.84%	32.56%	53.47%	62.52%	-735.06%	9.89%	607.28%
EPS Growth	-68.12%	-48.44%	9.52%	205.88%	204.55%	36.36%	50.00%	57.69%	-741.79%	15.56%	611.11%
Operating Cash Flow Growth	360.90%	-17.33%	91.29%	-62.29%	-2.63%	-30.47%	146.78%	547.31%	29.83%	-505.38%	1,357.72%
Free Cash Flow Firm Growth	-76.39%	-264.33%	-294.40%	99.71%	105.75%	83.80%	86.55%	222.89%	-54.60%	-15.92%	29.09%
Invested Capital Growth	19.51%	18.09%	15.88%	1.29%	0.66%	3.46%	3.18%	1.46%	-6.73%	3.71%	3.27%
Revenue Q/Q Growth	4.77%	-2.05%	-0.72%	3.22%	2.24%	-2.05%	-1.61%	4.20%	5.09%	1.52%	-3.19%
EBITDA Q/Q Growth	11.73%	-2.55%	17.56%	5.28%	7.01%	-19.53%	30.94%	7.47%	-336.35%	134.77%	26.58%
EBIT Q/Q Growth	-5.02%	7.11%	36.88%	10.32%	9.64%	-31.88%	59.41%	14.12%	-523.16%	117.49%	48.77%
NOPAT Q/Q Growth	139.27%	41.68%	-18.24%	9.28%	25.30%	-23.32%	26.00%	3.53%	-513.58%	118.71%	103.48%
Net Income Q/Q Growth	35.34%	59.04%	34.03%	12.78%	31.38%	-33.25%	55.17%	19.43%	-613.39%	111.55%	146.12%
EPS Q/Q Growth	29.41%	50.00%	39.39%	13.04%	28.85%	-32.84%	53.33%	18.84%	-624.39%	112.09%	120.69%
Operating Cash Flow Q/Q Growth	55.95%	85.05%	-106.22%	310.07%	302.72%	32.15%	-95.82%	2,806.61%	-19.23%	-512.61%	115.05%
Free Cash Flow Firm Q/Q Growth	16.31%	11.63%	7.63%	99.57%	1,748.18%	-349.01%	23.31%	103.90%	508.87%	-735.81%	42.28%
Invested Capital Q/Q Growth	0.27%	-2.44%	2.19%	1.32%	-0.35%	0.28%	1.91%	-0.38%	-8.39%	11.50%	1.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.73%	21.69%	24.60%	26.01%	26.15%	23.52%	26.58%	26.57%	26.57%	27.71%	26.90%
EBITDA Margin	10.25%	10.20%	12.08%	12.32%	12.89%	10.59%	14.09%	14.53%	-32.69%	11.19%	12.55%
Operating Margin	4.39%	4.65%	6.61%	7.07%	7.58%	5.27%	8.54%	8.49%	-37.66%	6.49%	7.52%
EBIT Margin	4.39%	4.80%	6.61%	7.07%	7.58%	5.27%	8.54%	9.35%	-37.66%	6.49%	7.52%
Profit (Net Income) Margin	1.64%	2.66%	3.59%	3.92%	5.04%	3.43%	5.41%	6.21%	-30.32%	3.45%	4.74%
Tax Burden Percent	99.20%	135.47%	78.37%	77.64%	88.73%	99.88%	78.95%	78.91%	77.67%	74.90%	84.68%
Interest Burden Percent	37.62%	40.91%	69.24%	71.45%	74.92%	65.22%	80.32%	84.10%	103.66%	71.00%	74.49%
Effective Tax Rate	0.80%	-35.47%	21.63%	22.36%	11.27%	0.12%	21.05%	21.10%	0.00%	25.10%	15.32%
Return on Invested Capital (ROIC)	4.06%	6.01%	4.87%	4.83%	5.96%	4.74%	5.98%	5.95%	-24.85%	4.43%	5.83%
ROIC Less NNEP Spread (ROIC-NNEP)	1.80%	2.71%	3.54%	3.56%	4.49%	3.05%	4.81%	5.48%	-29.09%	3.12%	4.40%
Return on Net Nonoperating Assets (RNNOA)	0.74%	0.98%	1.39%	1.36%	1.60%	0.99%	1.59%	1.71%	-8.77%	1.08%	1.54%
Return on Equity (ROE)	4.80%	7.00%	6.25%	6.18%	7.56%	5.73%	7.57%	7.66%	-33.61%	5.51%	7.37%
Cash Return on Invested Capital (CROIC)	-14.50%	-13.04%	-10.75%	3.17%	4.41%	1.70%	2.21%	4.15%	4.02%	-6.14%	-5.12%
Operating Return on Assets (OROA)	3.10%	3.39%	4.74%	4.88%	5.21%	3.69%	5.97%	6.55%	-25.53%	4.63%	5.47%
Return on Assets (ROA)	1.16%	1.88%	2.57%	2.71%	3.47%	2.40%	3.78%	4.34%	-20.55%	2.46%	3.45%
Return on Common Equity (ROCE)	4.80%	7.00%	6.25%	6.18%	7.56%	5.73%	7.57%	7.66%	-33.61%	5.51%	7.37%
Return on Equity Simple (ROE_SIMPLE)	2.97%	0.00%	2.72%	3.49%	4.48%	0.00%	5.07%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	8.54	12	9.89	11	14	10	13	14	-56	10	13
NOPAT Margin	4.35%	6.29%	5.18%	5.49%	6.73%	5.26%	6.74%	6.70%	-26.36%	4.86%	6.37%
Net Nonoperating Expense Percent (NNEP)	2.26%	3.31%	1.32%	1.27%	1.47%	1.69%	1.16%	0.47%	4.24%	1.31%	1.43%
Return On Investment Capital (ROIC_SIMPLE)	-	1.34%	1.09%	-	-	1.12%	1.40%	1.44%	-6.39%	1.09%	1.37%
Cost of Revenue to Revenue	77.27%	78.31%	75.40%	73.99%	73.85%	76.48%	73.42%	73.43%	73.43%	72.29%	73.10%
SG&A Expenses to Revenue	16.40%	16.11%	17.27%	18.31%	17.62%	17.29%	17.82%	17.78%	17.06%	17.40%	19.38%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.34%	17.04%	17.98%	18.94%	18.57%	18.25%	18.04%	18.08%	64.23%	21.23%	19.38%
Earnings before Interest and Taxes (EBIT)	8.61	9.22	13	14	15	10	17	19	-80	14	16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	20	20	23	24	26	21	27	29	-69	24	26
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.00	1.19	1.16	1.30	1.44	1.38	1.25	1.81	2.15	2.15	2.84
Price to Tangible Book Value (P/TBV)	2.88	3.38	3.13	3.37	3.59	3.26	2.86	3.99	5.21	4.99	6.42
Price to Revenue (P/Rev)	0.84	1.00	0.98	1.10	1.23	1.20	1.10	1.61	1.73	1.72	2.26
Price to Earnings (P/E)	33.54	47.71	42.68	37.32	32.18	29.87	24.64	32.10	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.98%	2.10%	2.34%	2.68%	3.11%	3.35%	4.06%	3.12%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.00	1.14	1.12	1.22	1.33	1.29	1.19	1.64	1.90	1.83	2.32
Enterprise Value to Revenue (EV/Rev)	1.17	1.30	1.28	1.40	1.51	1.46	1.36	1.86	1.95	2.04	2.58
Enterprise Value to EBITDA (EV/EBITDA)	10.89	12.60	12.82	12.49	12.70	12.17	10.95	14.50	244.80	147.05	129.55
Enterprise Value to EBIT (EV/EBIT)	21.94	26.43	27.87	24.49	23.11	21.95	19.19	24.86	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	33.16	34.91	30.30	27.67	26.42	25.72	22.64	29.49	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	23.97	31.60	20.27	25.50	27.92	33.53	29.45	26.59	26.31	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	38.82	30.35	77.23	54.73	39.80	45.62	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.43	0.42	0.41	0.40	0.39	0.36	0.35	0.33	0.35	0.46	0.45
Long-Term Debt to Equity	0.42	0.40	0.39	0.38	0.37	0.34	0.33	0.31	0.33	0.45	0.44
Financial Leverage	0.41	0.36	0.39	0.38	0.36	0.32	0.33	0.31	0.30	0.34	0.35
Leverage Ratio	1.86	1.84	1.82	1.76	1.75	1.70	1.69	1.67	1.81	1.72	1.70
Compound Leverage Factor	0.70	0.75	1.26	1.26	1.31	1.11	1.36	1.40	1.88	1.22	1.27
Debt to Total Capital	29.92%	29.39%	28.97%	28.53%	27.85%	26.20%	25.92%	24.57%	25.96%	31.45%	31.12%
Short-Term Debt to Total Capital	0.69%	0.87%	1.03%	1.19%	1.19%	1.35%	1.34%	1.33%	1.43%	0.52%	0.51%
Long-Term Debt to Total Capital	29.23%	28.52%	27.94%	27.34%	26.67%	24.85%	24.58%	23.24%	24.53%	30.93%	30.61%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	70.08%	70.61%	71.03%	71.47%	72.15%	73.80%	74.08%	75.43%	74.04%	68.55%	68.88%
Debt to EBITDA	3.37	3.40	3.45	3.01	2.77	2.57	2.46	2.26	35.47	26.59	18.09
Net Debt to EBITDA	3.03	2.85	3.03	2.67	2.37	2.18	2.15	1.90	27.53	22.62	15.75
Long-Term Debt to EBITDA	3.29	3.30	3.32	2.88	2.65	2.44	2.33	2.14	33.52	26.15	17.79
Debt to NOPAT	10.24	9.42	8.14	6.67	5.75	5.44	5.09	4.60	-9.05	-13.43	-17.30
Net Debt to NOPAT	9.22	7.89	7.15	5.92	4.92	4.61	4.45	3.86	-7.03	-11.43	-15.06
Long-Term Debt to NOPAT	10.01	9.14	7.85	6.39	5.51	5.16	4.83	4.36	-8.56	-13.21	-17.01
Altman Z-Score	2.33	2.56	2.57	2.75	2.95	2.98	2.95	3.55	2.62	3.31	3.93
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.93	2.99	2.99	3.06	3.21	3.24	3.34	3.24	2.04	3.50	3.67
Quick Ratio	0.69	0.80	0.72	0.73	0.82	0.84	0.86	0.85	0.49	0.95	1.02
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-135	-119	-110	-0.47	7.76	-19	-15	0.58	3.52	-22	-16
Operating Cash Flow to CapEx	280.03%	759.20%	-33.13%	104.34%	701.31%	508.11%	16.01%	525.19%	882.12%	-1,233.88%	388.76%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.71	0.71	0.72	0.69	0.69	0.70	0.70	0.70	0.68	0.71	0.73
Accounts Receivable Turnover	7.57	7.26	7.66	7.69	7.36	7.34	7.06	7.03	7.36	7.04	6.60
Inventory Turnover	3.06	3.21	2.94	2.91	2.94	2.98	2.89	2.96	3.16	3.18	3.20
Fixed Asset Turnover	6.92	6.96	7.00	6.97	7.05	7.11	7.14	7.22	7.43	7.60	7.83
Accounts Payable Turnover	7.05	7.31	6.48	7.41	7.65	7.96	7.14	7.34	7.44	8.02	7.66
Days Sales Outstanding (DSO)	48.20	50.30	47.67	47.48	49.57	49.75	51.68	51.94	49.57	51.82	55.28
Days Inventory Outstanding (DIO)	119.19	113.84	123.95	125.28	124.25	122.67	126.15	123.32	115.54	114.89	114.22
Days Payable Outstanding (DPO)	51.76	49.91	56.35	49.28	47.69	45.85	51.09	49.71	49.05	45.52	47.63
Cash Conversion Cycle (CCC)	115.63	114.23	115.28	123.49	126.14	126.56	126.74	125.54	116.07	121.18	121.87
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	879	858	877	888	885	888	905	901	826	921	933
Invested Capital Turnover	0.93	0.96	0.94	0.88	0.89	0.90	0.89	0.89	0.94	0.91	0.92
Increase / (Decrease) in Invested Capital	144	131	120	11	5.78	30	28	13	-60	33	30
Enterprise Value (EV)	878	982	980	1,087	1,180	1,146	1,078	1,477	1,571	1,680	2,167
Market Capitalization	634	760	749	854	960	941	866	1,284	1,394	1,422	1,904
Book Value per Share	$43.61	$43.58	$43.93	$44.57	$45.13	$46.18	$46.78	$47.58	$43.49	$44.30	$44.69
Tangible Book Value per Share	$15.11	$15.43	$16.26	$17.21	$18.12	$19.51	$20.45	$21.64	$17.92	$19.05	$19.79
Total Capital	907	901	909	918	922	925	935	938	877	966	972
Total Debt	271	265	263	262	257	242	242	231	228	304	303
Total Long-Term Debt	265	257	254	251	246	230	230	218	215	299	298
Net Debt	244	222	231	232	220	205	212	193	177	259	264
Capital Expenditures (CapEx)	5.11	3.49	4.97	3.32	1.99	3.63	4.82	4.27	2.05	6.05	2.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	346	331	353	364	366	368	387	389	309	407	427
Debt-free Net Working Capital (DFNWC)	373	374	385	394	404	405	418	426	360	452	466
Net Working Capital (NWC)	367	366	375	383	393	393	405	414	347	447	461
Net Nonoperating Expense (NNE)	5.33	6.99	3.04	3.09	3.40	3.61	2.58	1.00	8.41	3.04	3.40
Net Nonoperating Obligations (NNO)	244	222	231	232	220	205	212	193	177	259	264
Total Depreciation and Amortization (D&A)	12	10	10	10	11	10	11	10	11	10	11
Debt-free, Cash-free Net Working Capital to Revenue	45.90%	43.70%	46.01%	46.92%	46.88%	46.78%	48.99%	48.94%	38.29%	49.30%	50.77%
Debt-free Net Working Capital to Revenue	49.52%	49.36%	50.19%	50.70%	51.65%	51.50%	52.88%	53.61%	44.60%	54.79%	55.42%
Net Working Capital to Revenue	48.69%	48.33%	48.97%	49.30%	50.25%	49.92%	51.30%	52.04%	43.05%	54.18%	54.83%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.22	$0.33	$0.47	$0.52	$0.69	$0.45	$0.71	$0.84	($4.30)	$0.48	$0.66
Adjusted Weighted Average Basic Shares Outstanding	14.63M	13.72M	14.69M	14.78M	14.81M	14.77M	14.86M	14.94M	14.98M	14.94M	15.04M
Adjusted Diluted Earnings per Share	$0.22	$0.33	$0.46	$0.52	$0.67	$0.45	$0.69	$0.82	($4.30)	$0.52	$0.64
Adjusted Weighted Average Diluted Shares Outstanding	14.81M	13.97M	14.94M	14.96M	15.04M	15.01M	15.18M	15.22M	14.98M	14.94M	15.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	14.60M	14.64M	14.72M	14.75M	14.78M	14.81M	14.88M	14.92M	14.95M	14.99M	15.09M
Normalized Net Operating Profit after Tax (NOPAT)	12	7.51	11	12	15	12	13	14	14	11	13
Normalized NOPAT Margin	6.28%	3.90%	5.75%	5.98%	7.57%	6.22%	6.92%	6.94%	6.65%	5.07%	6.37%
Pre Tax Income Margin	1.65%	1.96%	4.58%	5.05%	5.68%	3.44%	6.86%	7.87%	-39.04%	4.61%	5.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Ducommun Inc. (DCO) has shown revenue growth in 2025 with a notable quarterly earnings turnaround in Q4, despite some quarterly cash-flow volatility and a one-time charge earlier in the year. Below are the key takeaways based on the last four years of quarterly statements.

Q4 2025 revenue rose to $215,798,000, up from $197,292,000 in Q4 2024, signaling continued top-line growth.
Gross margin improved to about 27.7% in Q4 2025 (gross profit $59,805,000 on $215,798,000 revenue) versus roughly 23.5% in Q4 2024.
Q4 2025 operating income turned positive at $13,998,000, reversing Q3’s large loss and showing improving operating leverage.
Q4 2025 net income attributable to common shareholders was $7,444,000, with basic earnings per share of $0.48 and diluted earnings per share of $0.52.
Net cash from financing activities in Q4 2025 was $73,127,000, supporting liquidity through financing activities.
As of Q3 2025, the company reported solid liquidity with about $681,350,000 in total current assets and $334,254,000 in total current liabilities (roughly a 2.0x current ratio).
Long-term debt around $215,046,000 and total liabilities about $599,525,000 versus equity of $649,045,000 indicate a moderate leverage profile (debt-to-equity near 0.9x).
Revenue has shown steady growth over the four-year period, with 2025 quarterly results continuing a multi-year upward trend.
Q3 2025 included a one-time charge of $99,675,000 categorized as Other Special Charges / (Income), net, contributing to a substantial quarterly loss.
Q4 2025 cash flow from continuing operating activities was negative at $-74,687,000, driven by a large non-cash adjustment and working capital movements, signaling near-term cash-flow volatility.

05/17/26 04:22 PM ETAI Generated. May Contain Errors.

Ducommun Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ducommun's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ducommun's net income appears to be on an upward trend, with a most recent value of -$37.35 million in 2025, falling from -$74.88 million in 2015. The previous period was $21.68 million in 2024. Check out Ducommun's forecast to explore projected trends and price targets.

Ducommun's total operating income in 2025 was -$35.74 million, based on the following breakdown:

Total Gross Profit: $221.62 million
Total Operating Expenses: $257.35 million

Over the last 10 years, Ducommun's total revenue changed from $666.01 million in 2015 to $824.84 million in 2025, a change of 23.8%.

Ducommun's total liabilities were at $524.93 million at the end of 2025, a 17.7% increase from 2024, and a 41.4% increase since 2015.

In the past 10 years, Ducommun's cash and equivalents has ranged from $0.00 in 2018 to $76.32 million in 2021, and is currently $45.29 million as of their latest financial filing in 2025.

Over the last 10 years, Ducommun's book value per share changed from 16.76 in 2015 to 44.30 in 2025, a change of 164.4%.

Related Companies

Financial statements for NYSE:DCO last updated on 5/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ducommun (DCO) Financials

Financials Breakdown Chart

Key Financial Trends

Ducommun Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ducommun (DCO) Financials

Annual Income Statements for Ducommun

Quarterly Income Statements for Ducommun

Annual Cash Flow Statements for Ducommun

Quarterly Cash Flow Statements for Ducommun

Annual Balance Sheets for Ducommun

Quarterly Balance Sheets for Ducommun

Annual Metrics And Ratios for Ducommun

Quarterly Metrics And Ratios for Ducommun

Financials Breakdown Chart

Key Financial Trends

Ducommun Financials - Frequently Asked Questions

When does Ducommun's financial year end?

How has Ducommun's net income changed over the last 10 years?

What is Ducommun's operating income?

How has Ducommun's revenue changed over the last 10 years?

How much debt does Ducommun have?

How much cash does Ducommun have?

How has Ducommun's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools